<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6701">
  <stage>Registered</stage>
  <submitdate>21/06/2017</submitdate>
  <approvaldate>21/06/2017</approvaldate>
  <nctid>NCT03197974</nctid>
  <trial_identification>
    <studytitle>RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT)</studytitle>
    <scientifictitle>Web-based Intervention With Email Support to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT): Randomised Controlled Trial</scientifictitle>
    <utrn />
    <trialacronym>ORBIT</trialacronym>
    <secondaryid>APP1102097</secondaryid>
    <secondaryid>ORBIT</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Bipolar Disorder, Currently in Remission</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Depression</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behaviour - Mindfulness for Bipolar
Behaviour - Psychoeducation for Bipolar

Other: Mindfulness for Bipolar - Introduction to, and training in the skills of mindfulness, self-compassion, and values-oriented action, and how these can be applied to managing symptoms of bipolar disorder.

Other: Psychoeducation for Bipolar - Information about bipolar disorder and the patient's role in managing the condition, including identifying triggers, and responding to early warning signs of episodes, and developing a healthy lifestyle


Behaviour: Mindfulness for Bipolar
Brief online self-management program with email coaching support

Behaviour: Psychoeducation for Bipolar
Brief online self-management program with email coaching support

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in Brief QoL.BD - Self-report measure to assess quality of life.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Montgomery-Asberg Depression Scale (MADRS) - A clinician-rated scale to assess depression symptoms.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Young Mania Rating Scale (YMRS) - A clinician-rated scale to assess manic symptoms.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) - A self-report measure of depression.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Depression Anxiety Stress Scale (DASS-21, Anxiety and Stress Scales only) - A self-report measure of anxiety and stress symptoms.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Functional Assessment Staging Test (FAST) - A clinician-rated scale to assess functioning across 6 different domains.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Pittsburgh Sleep Quality Index (PSQI) - A self-report measure of sleep quality.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Sleep, Circadian Rhythms and Mood questionnaire (SCRAM) - A self-report measure to assess overlap between sleep, cardiac rhythms and mood.</outcome>
      <timepoint>Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurrence of intervention-related relapse - Using the Time to Intervention for Mood Episode (TIME) and a modified version of the MINI International Neuropsychiatric Interview (MINI) to determine treatment-related relapse events.</outcome>
      <timepoint>Immediately post-intervention (post the 5 week active phase), 3 and 6 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>To ensure ready translation, minimally restrictive inclusion and exclusion criteria will be
        set.

        

          -  diagnosis of BD from a mental health professional

          -  diagnosis of BD (BD I, BD II or Other Specified Bipolar and Related Disorder)
             confirmed by semi-structured interview using DSM-5 (Diagnostic and statistical manual
             of mental disorders-5) criteria, excluding criteria that mania/hypomania require
             abnormalities of activity/energy.

          -  must have experienced 10 or more episodes of mania, hypomania or depression

          -  must be under the care of and able to provide phone/mail contact details for a
             nominated medical practitioner

          -  must have local access to emergency services

          -  must have sufficient understanding of written and spoken English

          -  must have ready daily access to the internet and adequate internet literacy

          -  aged between 18 - 65 years</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria:

          -  currently experiencing an episode of depression or hypo/mania

          -  currently psychotic or actively suicidal</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Other</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>14/09/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Swinburne University of Technology - Hawthorn</hospital>
    <postcode>3122 - Hawthorn</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Swinburne University of Technology</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of British Columbia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>National Health and Medical Research Council, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of California, Berkeley</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Lancaster University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Deakin University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Australian National University</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to improve outcomes in people with bipolar disorder (BD) by
      comparing two new online interventions specifically designed to improve quality of life
      amongst people who have had multiple (10 or more) episodes of BD.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT03197974</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Greg Murray</name>
      <address>Swinburne University of Technology</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Fiona Foley</name>
      <address />
      <phone>61 3 9214 5304</phone>
      <fax />
      <email>ffoley@swin.edu.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>